JPMorgan Funds - Thematics - Genetic Therapies A (dist) - CHF (hedged)
WKN A2PR30 | ISIN LU2053353665 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | LU0208607159 | Pictet - Biotech - P dy USD | +49,61 % | +26,20 % | 1,82 |
|
| 2 | LU0108459552 | Candriam Equities L Biotechnology, C - Distribution | +39,66 % | +21,88 % | 1,72 |
|
| 3 | IE00BF23BV98 | Polar Capital Funds plc - Biotechnology Fund Class S USD Distribution Shares | +40,17 % | +25,18 % | 1,51 |
|
| 4 | IE00B42Z4531 | Polar Capital Funds plc - Biotechnology Fund Class I USD Distribution Shares | +39,86 % | +25,19 % | 1,50 |
|
| 5 | IE00B3XLHR60 | Polar Capital Funds plc - Biotechnology Fund Class R USD Distribution Shares | +39,19 % | +25,18 % | 1,48 |
|
| 13 | LU2053353665 | JPMorgan Funds - Thematics - Genetic Therapies A (dist) - CHF (hedged) | +20,91 % | +23,28 % | 0,81 |
|
| 14 | AT0000746748 | ERSTE STOCK BIOTEC EUR R01 (A) | +17,72 % | +21,94 % | 0,72 |
|
| 15 | DE000A2DU172 | Allianz Biotechnologie - P - EUR | +15,45 % | +22,77 % | 0,59 |
|
| 16 | DE000A2AMPU5 | Allianz Biotechnologie - R - EUR | +15,38 % | +22,77 % | 0,59 |
|
| 17 | DE0008481862 | Allianz Biotechnologie - A - EUR | +14,38 % | +22,77 % | 0,54 |
|